Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasigna Alone or With Gleevec in Advanced GIST
NCT01089595Phase 2Terminated
- Sponsor
- Fox Chase Cancer Center
- Start
- Feb 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in gastrointestinal stromal tumor (GIST), sponsored by Fox Chase Cancer Center. Started Feb 2009; status: terminated.
02
Drugs
nilotinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01089595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01089595.